Ambassador Susan C. Schwab

Ambassador Schwab served as U.S. Trade Representative (2006–09) and as deputy (2005–06).

As USTR, she concluded free trade agreements with Peru, Colombia, South Korea and others; and launched the Trans-Pacific Partnership (TPP) negotiations.  She pursued and/or settled trade disputes with various WTO members, including China, Canada, and the EU, and engaged in negotiations at the WTO, APEC and other multilateral institutions.

In academia, she served as dean of the School of Public Policy at the University of Maryland; and as vice chancellor of the University System of Maryland (USM) & CEO of the USM Foundation.  She still teaches classes in international trade.

In the private sector, Schwab was director of corporate business development for Motorola, Inc., where she engaged in M&A and joint venture negotiations in Asia, including in China.

Earlier in government, she served as assistant secretary of Commerce and director-general of the U.S. & Foreign Commercial Service, as a trade staffer and legislative director for Senator John C. Danforth (R-MO), and as a foreign service officer at the US Embassy in Tokyo.  She began her career as an agricultural trade negotiator at USTR.

Ambassador Schwab serves on the boards of Caterpillar, FedEx and Marriott, as well as The Conference Board, Business Council for International Understanding (BCIU), Lee Kuan Yew School of Public Policy, and Signature Theatre of Arlington, VA.  She chairs the board of The National Foreign Trade Council (NFTC).

She holds a BA from Williams College; a Master’s from Stanford University; and a Ph.D. from The George Washington University.

The United States Cannot Afford Disarray as China Strengthens Its Biopharmaceutical Industry

By Sujai Shivakumar, Charles Wessner, and Julie Heng For years, China has played a leading role in manufacturing active pharmaceutical ingredients and generic drugs. While securing the supply chain for active pharmaceutical ingredients is increasingly recognized as a national security priority by policymakers, China’s growing role in biotechnological innovation has
Read More

Explainer: A Brief History of the International IP Regime

By Julie Heng, Arrizka Faida, and Chris Borges In a globalized economy, businesses rely on rules protecting intellectual property (IP) to safeguard their ideas and products against counterfeiting, piracy, and theft and to forge international partnerships. To this end, the United States and its partners have long invested in a system of multilateral treaties and international
Read More

ChinaTalk: Innovation Emergency with Trump 1.0’s Patent Director

On February 19th, CSIS Senior Adviser Andrei Iancu appeared on the ChinaTalk podcast to discuss how patents influence emerging technology innovation, how far AI and DOGE could push the current U.S. IP regime, if it matters that China issues more patents than the United States, and more. Listen to the
Read More